Lei Dai

机构：University of British Columbia, BC Children's Hospital · ORCID：0000-0001-8448-3043

发表论文 87 篇 · 总被引 2092 次 · h-index 26

代表论文

• Intravesical chemotherapy synergize with an immune adjuvant by a thermo-sensitive hydrogel system for bladder cancer (2023 · Bioactive Materials · 被引 46)
• Colitis-associated carcinogenesis: crosstalk between tumors, immune cells and gut microbiota (2023 · Cell & Bioscience · 被引 41)
• Reduced smooth muscle-fibroblasts transformation potentially decreases intestinal wound healing and colitis-associated cancer in ageing mice (2023 · Signal Transduction and Targeted Therapy · 被引 28)
• A novel membrane-bound interleukin-2 promotes NK-92 cell persistence and anti-tumor activity (2022 · OncoImmunology · 被引 23)
• A 3D-printed microdevice encapsulates vascularized islets composed of iPSC-derived β-like cells and microvascular fragments for type 1 diabetes treatment (2024 · Biomaterials · 被引 17)
• Univariable and multivariable Mendelian randomization study identified the key role of gut microbiota in immunotherapeutic toxicity (2024 · European journal of medical research · 被引 9)